(TSX-V:EMO),(OTC US:EMOTF),(Other OTC:EMOTF),(Frankfurt:LLJA), TORONTO, Sept. 19, 2025 (GLOBE NEWSWIRE) — Emerita Resources Corp. (TSX-V: EMO; OTCQB: EMOTF; FSE: LLJA) (the “Company” or “Emerita”) is pleased to announce that the Ministry of Industrial Policy and Energy of Huelva, Andalusia has granted the Company exploration permits for the San Antonio and Terranova claims (collectively, the “New Properties”) […]

(NasdaqGM:SKYE), SAN DIEGO, Sept. 19, 2025 (GLOBE NEWSWIRE) — Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biotechnology company focused on unlocking new therapeutic pathways for obesity and other metabolic health disorders, today announced the presentation of results from the Phase 1b study of nimacimab in subjects with metabolic-associated steatotic liver disease (MASLD) at the

(TSX-V:HEVI), CALGARY, Alberta, Sept. 19, 2025 (GLOBE NEWSWIRE) — Helium Evolution Incorporated (TSXV:HEVI) (“HEVI” or the “Company“), a Canadian-based helium exploration and development company announces the resignation of its President & Chief Executive Officer, Greg Robb. The Board of Directors has appointed Jim Baker, the Company's Chairman, as Interim Chief Executive Officer, effective September 18,

(CNSX:RSG.CN),(Pinksheets:CNOBF),(PinkSheets:CNOBF), Not for dissemination to the United States Newswire Services or dissemination in the United States TORONTO, Sept. 19, 2025 (GLOBE NEWSWIRE) — Rocky Shore Gold Ltd. (“Rocky Shore” or the “Company“) (CSE: RSG) is pleased to announce that, due to the high level of interest, it has increased the size of its previously announced

(NASDAQ:SNDX), NEW YORK, Sept. 19, 2025 (GLOBE NEWSWIRE) — Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that the National Comprehensive Cancer Network(R) (NCCN(R)) Clinical Practice Guidelines in Oncology (NCCN Guidelines(R)) for Acute Myeloid Leukemia were updated to include revumenib as a category 2A recommendation for relapsed or refractory

(NASDAQ:REGN), Inmazeb(R) (atoltivimab, maftivimab, and odesivimab-ebgn) was the first treatment approved by the U.S. Food and Drug Administration (FDA) for Orthoebolavirus zairense, also known as Zaire ebolavirus Supply is being rushed to Democratic Republic of Congo (DRC) to help with the current outbreak TARRYTOWN, N.Y., Sept. 19, 2025 (GLOBE NEWSWIRE) — Regeneron Pharmaceuticals, Inc. (NASDAQ:

NEW YORK, Sept. 19, 2025 (GLOBE NEWSWIRE) — Samsung Electronics, in collaboration with Niio, unveils Code of Nature — an immersive, generative digital art installation designed for The Wall LED display in the lobby of its Germany office in Eschborn. This striking installation transforms the space into a living canvas, reflecting Samsung's commitment to innovation,

WeRide Robobus Receives Belgium's First Level 4 Permit, Leading AV Industry with Products Licensed in Seven Countries GlobeNewswire September 19, 2025 ANTWERP, Belgium, Sept. 19, 2025 (GLOBE NEWSWIRE) — WeRide (Nasdaq: WRD), a global leader in autonomous driving technology, today announced that its Robobus has received Belgium's first federal test permit for a Level 4

Emerita Granted Two Additional Properties in the IBW Area, “San Antonio” and “Terranova” Exploration Permits and Enters Into Agreement to Acquire the Nueva Celti Project in Andalusia, Spain GlobeNewswire September 19, 2025 TORONTO, Sept. 19, 2025 (GLOBE NEWSWIRE) — Emerita Resources Corp. (TSX-V: EMO; OTCQB: EMOTF; FSE: LLJA) (the “Company” or “Emerita”) is pleased to

Rocky Shore Gold Announces Upsize of Private Placement GlobeNewswire September 19, 2025 Not for dissemination to the United States Newswire Services or dissemination in the United States TORONTO, Sept. 19, 2025 (GLOBE NEWSWIRE) — Rocky Shore Gold Ltd. (“Rocky Shore” or the “Company“) (CSE: RSG) is pleased to announce that, due to the high level